Clinical Trials Directory

Trials / Unknown

UnknownNCT05602129

A Clinical Study to Evaluate the Efficacy, Safety and PK/PD Profiles of Anticoagulation of HSK36273 for Injection in Continuous Renal Replacement Therapy Subjects

A Multi-center, Randomized, Open, Positive-controlled Two-stage Phase II Clinical Study to Evaluate the Efficacy, Safety and PK/PD Profiles of Anticoagulation of HSK36273 for Injection in Continuous Renal Replacement Therapy Subjects

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
156 (estimated)
Sponsor
Haisco Pharmaceutical Group Co., Ltd. · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study is divided into Stage I and Stage II. It is planned to include 156 subjects who need CRRT treatment for more than 48 hours.

Conditions

Interventions

TypeNameDescription
DRUGHSK36273HSK36273
DRUGHeparin sodiumHeparin sodium

Timeline

Start date
2022-11-01
Primary completion
2023-10-01
Completion
2023-10-01
First posted
2022-11-01
Last updated
2022-11-02

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05602129. Inclusion in this directory is not an endorsement.